Ovarian cancer is the seventh most common cancer in the world and the fifth most common cause of death from cancer; it is responsible for over half of all deaths related to gynecological cancers. The presence of lymphatic metastasis is an important prognostic factor in ovarian cancer. Nodal metastases to the pelvic and the para-aortic lymph nodes are common, particularly in an advanced of the disease (stages III-IV). The finding of distant nodal metastasis, especially subclavian lymph node metastasis, from ovarian carcinoma is very uncommon. 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) or FDG-PET/ computed tomography (CT) provides an improved imaging for detecting metastatic lymph nodes in patients with ovarian cancer. Immunohistochemically, ovarian carcinoma cells are positive for estrogen receptor, progesterone receptor, cancer antigen 125, Wilms' tumor 1 protein, and p53; they are negative for thyroid transcription factor (TTF-1) and caudal-related homeobox 2 (CDX-2). This report describes a Korean woman diagnosed with ovarian cancer with subclavian lymph node metastasis revealed by FDG PET/CT and verified by an immunohistochemical staining. Differentiating between the primary ovarian lesion and the metastatic lesion will allow the initiation of an appropriate treatment and help predict the prognosis (J Menopausal Med 2014;20:43-46)
Introduction
Ovarian cancer is the fifth most common cause of death from cancer and represents over half of all deaths related to gynecological cancers. 1, 2 Epithelial ovarian cancer classically spreads by exfoliation of cancerous cells into the intraabdominal cavity, movement of the cells through lymphatic channels, and hematogenous dissemination. Lymph nodes are involved in about 50-70% of cases of advanced ovarian cancer. 3, 4 The presence of lymphatic metastasis is an important prognostic factor in ovarian cancer. 3,5~7 Nodal metastases to the pelvic and para-aortic lymph nodes are common, particularly in advanced disease (stages III-IV). On physical examination, a mass was not palpable.
Ultrasonography of the neck was performed, which showed 
Discussion
The most common routes for spread of ovarian cancer are lymphatic dissemination through the nearby internal organs.
The most frequent sites of lymph node involvement are the abdominal (47%), para-aortic (38%), mediastinal (29%), and pelvic (17%) regions. 14 Extra-abdominal metastasis is considered to be infrequent. Especially, metastases to subclavian lymph nodes has rarely been reported in ovarian cancer.
Several studies have shown that distant lymph node metastases in ovarian cancer can be detected by FDG-PET/CT and it was shown that preoperative FDG PET/ CT can be a useful tool. But pathological confirmation of the PET/CT-positive lymph nodes was not performed. 9, 11, 12 Although the histologic diagnosis of metastatic lesions can be difficult, immunohistochemistry has made the diagnosis of these lesions more accurate. The markers that helped to confirm the diagnosis were ER, PR, CA-125, ST1, and p53. Furthermore, the negative TTF-1 and CDX2 staining indicated that the carcinoma was not pulmonary or colorectal carcinoma. TTF-1 is a selective marker of adenocarcinoma of pulmonary origin in cytologic preparations. 15 In our case, Differentiating between the primary ovarian lesion and the metastatic lesion allowed for the initiation of the appropriate treatment and helped determine the prognosis.
